Related references
Note: Only part of the references are listed.Smoking and Cardiovascular Disease Mechanisms of Endothelial Dysfunction and Early Atherogenesis
Barbara Messner et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
Snus (Swedish smokeless tobacco) use and risk of stroke: pooled analyses of incidence and survival
J. Hansson et al.
JOURNAL OF INTERNAL MEDICINE (2014)
Estimating the Harms of Nicotine-Containing Products Using the MCDA Approach
David J. Nutt et al.
EUROPEAN ADDICTION RESEARCH (2014)
Urinary biomarkers of smokers' exposure to tobacco smoke constituents in tobacco products assessment: a fit for purpose approach
Evan O. Gregg et al.
BIOMARKERS (2013)
Use of snus and acute myocardial infarction: pooled analysis of eight prospective observational studies
Jenny Hansson et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2012)
Differential exposure biomarker levels among cigarette smokers and smokeless tobacco consumers in the National Health and Nutrition Examination Survey 1999-2008
Ziad S. Naufal et al.
BIOMARKERS (2011)
Impact of Smokeless Tobacco Products on Cardiovascular Disease: Implications for Policy, Prevention, and Treatment A Policy Statement From the American Heart Association
Mariann R. Piano et al.
CIRCULATION (2010)
Exposure of the US Population to Acrylamide in the National Health and Nutrition Examination Survey 2003-2004
Hubert W. Vesper et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2010)
Systematic review of the relation between smokeless tobacco and cancer in Europe and North America
Peter N. Lee et al.
BMC MEDICINE (2009)
A cross-sectional investigation of biomarkers of risk after a decade of smoking
Gioacchino Calapai et al.
INHALATION TOXICOLOGY (2009)
Population estimates for biomarkers of exposure to cigarette smoke in adult US cigarette smokers
Hans J. Roethig et al.
NICOTINE & TOBACCO RESEARCH (2009)
The Strategic Dialogue on Tobacco Harm Reduction: a vision and blueprint for action in the US
Mitchell Zeller et al.
TOBACCO CONTROL (2009)
Exposure to nicotine and a tobacco-specific carcinogen increase with duration of use of smokeless tobacco
S. S. Hecht et al.
TOBACCO CONTROL (2008)
Similar exposure to a tobacco-specific carcinogen in smokeless tobacco users and cigarette smokers
Stephen S. Hecht et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Tobacco-related disease mortality among men who switched from cigarettes to spit tobacco
S. Jane Henley et al.
TOBACCO CONTROL (2007)
Biomarkers to assess the utility of potential reduced exposure tobacco products (vol 8, pg 169, 2006)
D. K. Hatsukami et al.
NICOTINE & TOBACCO RESEARCH (2006)
Effect of creatinine and specific gravity normalization techniques on xenobiotic biomarkers in smokers' spot and 24-h urines
DL Heavner et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2006)
Biomonitoring of inhaled complex mixtures - Ambient air, diesel exhaust and cigarette smoke
G Scherer
EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY (2005)
Two large prospective studies of mortality among men who use snuff or chewing tobacco (United States)
SJ Henley et al.
CANCER CAUSES & CONTROL (2005)
Tobacco-specific nitrosamines and their pyridine-N-glucuronides in the urine of smokers and smokeless tobacco users
I Stepanov et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
Cigarette smoking and cardiovascular disease: Pathophysiology and implications for treatment
NL Benowitz
PROGRESS IN CARDIOVASCULAR DISEASES (2003)
Liquid chromatographic/tandem mass spectrometric method for the determination of the tobacco-specific nitrosamine metabolite NNAL in smokers' urine
GD Byrd et al.
JOURNAL OF MASS SPECTROMETRY (2003)
Simultaneous determination of nicotine and eight nicotine metabolites in urine of smokers using liquid chromatography-tandem mass spectrometry
M Meger et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2002)
Clearing the smoke: the science base for tobacco harm reduction - executive summary (Reprinted from National Academy Press, 2001)
K Stratton et al.
TOBACCO CONTROL (2001)
Effects of occupation, lifestyle and genetic polymorphisms of CYP1A1, CYP2E1, GSTM1 and GSTT1 on urinary 1-hydroxypyrene and 2-naphthol concentrations
HM Nan et al.
CARCINOGENESIS (2001)
Urinary monohydroxylated phenanthrenes and hydroxypyrene - the effects of smoking habits and changes induced by smoking on monooxygenase-mediated metabolism
U Heudorf et al.
INTERNATIONAL ARCHIVES OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH (2001)
Smoking vs other risk factors as the cause of smoking-attributable deaths - Confounding in the courtroom
MJ Thun et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)